Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions

Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions

Abstract Background Comorbidities can complicate the management of severe asthma; therefore, the presence of comorbid conditions or traits often need to be considered when considering treatment options for patients with severe asthma. The aim of this analysis is to investigate the efficacy of mepoli...

Full description

Bibliographic Details
Main Authors: Peter G. Gibson, Charlene M. Prazma, Geoffrey L. Chupp, Eric S. Bradford, Mark Forshag, Stephen A. Mallett, Steve W. Yancey, Steven G. Smith, Elisabeth H. Bel
Format: Article
Language:English
Published: BMC 2021-06-01
Series:Respiratory Research
Subjects:
Mepolizumab
Severe eosinophilic asthma
Comorbidities
Upper respiratory
Cardiovascular
Treatable traits
Online Access:https://doi.org/10.1186/s12931-021-01746-4

Internet

https://doi.org/10.1186/s12931-021-01746-4

Similar Items